Effect of β-crytoxanthin on circulating bone metabolic markers: Intake of juice ( Citrus Unshiu) supplemented with β-cryptoxanthin has an effect in menopausal women

Journal of Health Science

Volumn 52, Issue 6, 2006, Pages 758-768

  Yamaguchi, Masayoshi ^a   Igarashi, Aki ^a   Uchiyama, Satoshi ^a   Sugawara, Kuniaki ^b   Sumida, Takashi ^b   Morita, Seiichi ^b   Ogawa, Hiroshi ^b   Nishitani, Masahito ^c   Kajimoto, Yoshitaka ^d  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Ehime Beverage Inc   (Japan)

^c Soiken Clinic   (Japan)

^d Soiken Inc   (Japan)

Author keywords

cryptoxanthin; Bone formation; Bone metabolic marker; Bone resorption; Menopause; Osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BETA CRYPTOXANTHIN; BIOLOGICAL MARKER; CALCIUM; GAMMA CARBOXYLATED OSTEOCALCIN; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CIRCULATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENOPAUSE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; SATSUMA;

CITRUS UNSHIU;

EID: 33845410105     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.52.758     Document Type: Article

References (34)

1. Albright, F., Smith, P. H. and Richardson, A. M. (1941) Postmenopausal osteoporosis: its clinical features. J. Am. Med. Assoc., 116, 2465-2474.
2. Riggs, B. L., Jowsey, J., Kelly, P. J., Jones, J. D. and Maker, F. I. (1969) Effect of sex hormones on bone in primary osteoporosis. J. Clin. Invest., 48, 1065-1072.
3. Cooper, C. and Melton, J., III (1992) Epidemiology of osteoporosis. Trends Endocrinol. Metab., 3, 224-229.
4. Bonjour, J.-P., Schurch, M.-A. and Rissori, R. (1996) Nutritional aspects of hip fractures. Bone, 18, 1395-1445.
5. Yamaguchi, M. (2002) Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J. Health Sci., 48, 209-222.
6. Yamaguchi, M. and Gao, Y. H. (1998) Anabolic effect of genistein and genistin on bone metabolism in the femoral-metaphyseal tissues of elderly rats: The genistein effect is enhanced by zinc. Mol. Cell. Biochem., 178, 377-382.
7. Sugimoto, E. and Yamaguchi, M. (2000) Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem. Pharmacol., 59, 471-475.
8. Yamaguchi, M. and Gao, Y. H. (1998) Inhibitory effect of genistein on bone resorption in tissue culture. Biochem. Pharmacol., 55, 71-76.
9. Gao, Y. H. and Yamaguchi, M. (1999) Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol., 58, 767-772.
10. 2) on osteoblastic bone formation in vitro. Mol. Cell. Biochem., 223, 131-137.
11. 2 (menaquinone-7) prevents bone loss in ovariectomized rats. J. Bone Miner. Metab., 18, 71-76.
12. 2 (menaquinone-7) enhanced circulating γ-carboxylated osteocalcin concentration in normal individuals. J. Health Sci., 46, 317-321.
13. Ono, R., Ma, Z. J. and Yamaguchi, M. (2000) Prolonged intake of fermented soybean diets with supplementation of isoflavone and saponin prevents bone loss in ovariectomized rats. J. Health Sci., 46, 70-74.
14. 2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovarientomized rats. J. Bone Miner. Metab., 17, 23-29.
15. Yamaguchi, M. and Uchiyama, S. (2003) Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: The unique anabolic effect of β-cryptoxanthin. Biol. Pharm. Bull., 26, 1188-1191.
16. Yamaguchi, M. and Uchiyama, S. (2004) β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol. Cell. Biochem., 258, 137-144.
17. Uchiyama, S. and Yamaguchi, M. (2005) β-Cryp toxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 15, 675-681.
18. Uchiyama, S. and Yamaguchi, M. (2005) β-Cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J. Cell. Biochem., 95, 1224-1234.
19. Uchiyama, S. and Yamaguchi, M. (2004) Inhibitory effect of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol., 67, 1297-1305.
20. Uchiyama, S. and Yamaguchi, M. (2006) β-Cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: Change in their related gene expression. J. Cell. Biochem., 98, 1185-1195.
21. Uchiyama, S., Sumida, T. and Yamaguchi, M. (2004) Oral administration of β-cryptoxanthin induces anabolic effects on bone components in the femoral tissues of rats in vivo. Biol. Pharm. Bull., 27, 232-235.
22. Uchiyama, S., Sumida, T. and Yamaguchi, M. (2004) Anabolic effect of β-cryptoxanthin on bone components in the femoral tissues of aged rats in vivo and in vitro. J. Health Sci., 50, 491-496.
23. Uchiyama, S. and Yamaguchi, M. (2005) Oral administration of β-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol. Pharm. Bull., 28, 1766-1769.
24. Uchiyama, S. and Yamaguchi, M. (2006) Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int. J. Mol. Med., 17, 15-20.
25. Yamaguchi, M., Igarashi, A., Uchiyama, S., Morita, S., Sugawara, K. and Sumida, T. (2004) Prolonged intake of juice (Citrus unshiu) reinforced with β-cryptoxanthin has an effect on circulating bone biochemical markers in normal individuals. J. Health Sci., 50, 619-624.
26. Yamaguchi, M., Igarashi, A., Morita, S., Sumida, T. and Sugawara, K. (2005) Relationship between serum β-cryptoxanthin and circulating bone metabolic markers in healthy individuals with the intake of juice (Citrus unshiu) containing β-cryptoxanthin. J. Health Sci., 51, 738-743.
27. Peng, Y.-M., Peng, Y.-S., Lin, Y., Moon, T., Roe, D. J. and Ritenbaugh, C. (1995) Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids and tocopherols in humans. Nutr. Cancer, 23, 233-246.
28. Koyama, N., Ohara, K., Yokota, H., Kurome, T., Katayama, M., Hino, F., Kato, I. and Aki, T. (1991) A one step sandwich enzyme immunoassay for antibodies. J. Immunol. Methods, 139, 17-23.
29. Gomez, B., Ardakani, S., Ju, J., Jenkins, D., Cerelli, M. J., Daniloff, G. Y. and Kung, V. T. (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin. Chem., 41, 1560-1566.
30. Hallen, J. M., Alatalo, S. L., Suminen, H., Cheng, S., Janckila, A. J. and Vaananen, H. K. (2000) Tartrate-resistant acid phosphatase 5b: A novel serum marker of none resorption. J. Biol. Miner. Res., 15, 1337-1345.
31. Clements, J. D., Herrich, M. V., Singer, F. R. and Eyre, D. R. (1997) Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin. Chem., 43, 2058-2063.
32. McElgot, A. J., Rock, C. L., Shanks, T. G., Flatt, A. W., Newman, V., Faerber, S. and Pierce, J. P. (1999) Comparison of serum carotenoid response between women consuming vegetable juice and woman consuming raw or cooked vegetable. Cancer Epidemiol. Biomarkers Prev., 8, 227-231.
33. Price, P. A. (1985) Vitamin K-dependent formation of bone gla protein (osteocalcin) and its function. Vitam. Horm., 42, 65-108.
34. Levy, J. R., Murray, E., Manolagass, S. and Olefsky, J. M. (1986) Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology, 119, 1786-1792.